Increased metabolic potential, efficacy, and safety of emerging treatments in schizophrenia

JM Meyer, CU Correll - CNS drugs, 2023 - Springer
Patients with schizophrenia experience a broad range of detrimental health outcomes
resulting from illness severity, heterogeneity of disease, lifestyle behaviors, and adverse …

A Novel Gliotransmitter, L-β-Aminoisobutyric Acid, Contributes to Pathophysiology of Clinical Efficacies and Adverse Reactions of Clozapine

K Fukuyama, E Motomura, M Okada - Biomolecules, 2023 - mdpi.com
Clozapine is listed as one of the most effective antipsychotics and has been approved for
treating treatment-resistant schizophrenia (TRS); however, several type A and B adverse …

[HTML][HTML] Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial

S Sethi, D Wakeham, T Ketter, F Hooshmand… - Psychiatry …, 2024 - Elsevier
The ketogenic diet (KD, also known as metabolic therapy) has been successful in the
treatment of obesity, type 2 diabetes, and epilepsy. More recently, this treatment has shown …

In vivo techniques for assessment of insulin sensitivity and glucose metabolism

MK Hahn, A Giacca, S Pereira - Journal of Endocrinology, 2024 - joe.bioscientifica.com
Metabolic tests are vital to determine in vivo insulin sensitivity and glucose metabolism in
preclinical models, usually rodents. Such tests include glucose tolerance tests, insulin …

Antipsychotic-induced dysregulation of glucose metabolism through the central nervous system: a scoping review of animal models

E Au, KJ Panganiban, S Wu, K Sun, B Humber… - Biological Psychiatry …, 2024 - Elsevier
The use of antipsychotic drugs is associated with adverse metabolic effects. Disruptions in
glucose metabolism such as hyperglycemia and insulin resistance have been shown to …

Olanzapine's effects on hypothalamic transcriptomics and kinase activity

S Pereira, LN Castellani, C Kowalchuk… - …, 2024 - Elsevier
Olanzapine is a second-generation antipsychotic that disrupts metabolism and is associated
with an increased risk of type 2 diabetes. The hypothalamus is a key region in the control of …

Intranasal insulin increases brain glutathione (GSH) and enhances antioxidant capacity in healthy participants, but not in those with early psychotic disorders.

VA Chouinard, W Feizi, X Chen, B Ren… - Biological Psychiatry …, 2024 - Elsevier
Background We examined the acute effects of intranasal insulin on cognitive function and
brain glutathione, a central factor in resistance to oxidative stress, in both participants with …

Allyl isothiocyanate, a TRPA1 agonist, protects against olanzapine-induced hypothalamic and hepatic metabolic aberrations in female mice

RK Sodhi, H Kumar, R Singh, Y Bansal, Y Singh… - Biochemical …, 2024 - Elsevier
Olanzapine, a widely prescribed atypical antipsychotic, poses a great risk to the patient's
health by fabricating a plethora of severe metabolic and cardiovascular adverse effects …

Neuronal alterations in AKT isotype expression in schizophrenia

EA Devine, AS Imami, H Eby, S Sahay, A Hamoud… - Molecular …, 2024 - nature.com
Schizophrenia is characterized by substantial alterations in brain function, and previous
studies suggest insulin signaling pathways, particularly involving AKT, are implicated in the …

Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia

A Bonifazi, M Ellenberger, ZJ Farino, D Aslanoglou… - Diabetes, 2024 - Am Diabetes Assoc
Dopamine (DA) D2-like receptors in both the central nervous system (CNS) and the
periphery are key modulators of metabolism. Moreover, disruption of D2-like receptor …